Cardiology - Medtelligence

17-32 of 130

From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Ahmad Masri, MD, MS; Anjali Owens, MD
1.00 program credit
- Ahmad Masri, MD, MS
- Anjali Owens, MD
1.00 program credit
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Michael Nassif, MD, MSc; Anjali Owens, MD
1.00 program credit
- Michael Nassif, MD, MSc
- Anjali Owens, MD
1.00 program credit
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
MinuteCE®
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
Ahmad Masri, MD, MS; Anjali Owens, MD
1.00 program credit
- Ahmad Masri, MD, MS
- Anjali Owens, MD
1.00 program credit
MinuteCE®
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Ahmad Masri, MD, MS; Michael Nassif, MD, MSc
1.00 credit 8 episodes
- Ahmad Masri, MD, MS
- Michael Nassif, MD, MSc
- Anjali Owens, MD
1.00 credit 8 episodes
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA; Nihar R. Desai, MD, MPH
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Cardiology
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Roxana Mehran, MD, FSCAI
- Roxana Mehran, MD, FSCAI
The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Cardiology
The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
- Pam R. Taub, MD, FACC, FASPC
Future Directions in Managing Hyperkalemia in CKD and HF
Future Directions in Managing Hyperkalemia in CKD and HF
MinuteCE®
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA; James Burton, DM, FRCP
1.00 program credit
- Javed Butler, MD, MPH, MBA
- James Burton, DM, FRCP
1.00 program credit
MinuteCE®
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
James Burton, DM, FRCP; Javed Butler, MD
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 credit 9 episodes
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
MinuteCE®
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
James Burton, DM, FRCP; Patrick Rossignol, MD, PhD
1.00 program credit
- James Burton, DM, FRCP
- Patrick Rossignol, MD, PhD
1.00 program credit
Potassium Binders in Practice: Clinical Trial Evidence
Potassium Binders in Practice: Clinical Trial Evidence
MinuteCE®
Potassium Binders in Practice: Clinical Trial Evidence
Ellie Kelepouris, MD, FACP, FAHA; Patrick Rossignol, MD, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
MinuteCE®
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
James Burton, DM, FRCP; Javed Butler, MD, MPH, MBA
1.00 program credit
- James Burton, DM, FRCP
- Javed Butler, MD, MPH, MBA
1.00 program credit
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
MinuteCE®
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Ellie Kelepouris, MD, FACP, FAHA; Patrick Rossignol, MD, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Potassium Binders: Safety Comes First!
Potassium Binders: Safety Comes First!
MinuteCE®
Potassium Binders: Safety Comes First!
Ellie Kelepouris, MD, FACP, FAHA; Javed Butler, MD, MPH, MBA
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Javed Butler, MD, MPH, MBA
1.00 program credit
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
MinuteCE®
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
James Burton, DM, FRCP; Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- James Burton, DM, FRCP
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
The Clinical Weight of TTR: What the Latest Data Reveal
The Clinical Weight of TTR: What the Latest Data Reveal
CME/CE
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS; Rola Khedraki, MD, FACC
0.25 credits
- Ahmad Masri, MD, MS
- Rola Khedraki, MD, FACC
0.25 credits

2/7